Inotuzumab ozogamicin and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Inotuzumab ozogamicin and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab Ozogamicin
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin-Insulin glulisine
- Inotuzumab ozogamicin-Insulin Glulisine (Cartridges and Pens)
- Inotuzumab ozogamicin-Insulin Glulisine (Vials)
- Inotuzumab ozogamicin-Insulin glulisine Subcutaneous
- Inotuzumab ozogamicin-Insulin human inhaled Inhalation
- Inotuzumab ozogamicin-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Inotuzumab ozogamicin Intravenous
- Insulin glargine, recombinant Subcutaneous-Inova
- Insulin glargine, recombinant Subcutaneous-Inova 4/1 topical
- Insulin glargine, recombinant Subcutaneous-Inova 8/2 topical
- Insulin glargine, recombinant Subcutaneous-Inova ACT
- Insulin glargine, recombinant Subcutaneous-Inrebic